Explore more publications!
Wellness Today St. Kitts & Nevis
Got News to Share?

Wellness Today St. Kitts & Nevis: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Today St. Kitts & Nevis.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on March 12, 2026

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
23 minutes ago

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Indeterminate GlobeNewswire
Koelis Announces Innovative Products at EAU 2026 enhancing MRI Fusion Biopsy Workflows and promoting Focal Therapy in Prostate Cancer
an hour ago

Koelis Announces Innovative Products at EAU 2026 enhancing MRI Fusion Biopsy Workflows and promoting Focal Therapy in Prostate Cancer

Indeterminate GlobeNewswire
SK pharmteco Announces CGMP Qualification of its Commercial-Scale Viral Vector Manufacturing Facility in France
3 hours ago

SK pharmteco Announces CGMP Qualification of its Commercial-Scale Viral Vector Manufacturing Facility in France

Indeterminate GlobeNewswire
Cbio A/S Receives European Regulatory Clearance to Begin First-in-Human Clinical Trial of Next-Generation T-Cell Therapy in late-stage Cervical Cancer
3 hours ago

Cbio A/S Receives European Regulatory Clearance to Begin First-in-Human Clinical Trial of Next-Generation T-Cell Therapy in late-stage Cervical Cancer

Indeterminate GlobeNewswire
Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia
3 hours ago

Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia

Indeterminate GlobeNewswire
Allegro’s osteoarthritis hydrogel resolves lameness in animal study
3 hours ago

Allegro’s osteoarthritis hydrogel resolves lameness in animal study

Indeterminate GlobeNewswire
Novo Holdings announces 2025 Annual Results
4 hours ago

Novo Holdings announces 2025 Annual Results

Indeterminate GlobeNewswire
Ipsen appoints Michelle C. Werner as EVP, President of North America
4 hours ago

Ipsen appoints Michelle C. Werner as EVP, President of North America

Indeterminate GlobeNewswire
Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow
5 hours ago

Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow

Indeterminate GlobeNewswire
BioVersys Announces First Patient Dosed in Phase 2b Clinical Trial of AlpE in Pulmonary Tuberculosis
5 hours ago

BioVersys Announces First Patient Dosed in Phase 2b Clinical Trial of AlpE in Pulmonary Tuberculosis

Indeterminate GlobeNewswire
Handelsupdate für das Geschäftsjahr 2025
5 hours ago

Handelsupdate für das Geschäftsjahr 2025

Indeterminate GlobeNewswire
Full Year 2025 Trading Update
5 hours ago

Full Year 2025 Trading Update

Indeterminate GlobeNewswire
AMA: AI Usage Among Doctors Doubles as Confidence in Technology Grows
7 hours ago

AMA: AI Usage Among Doctors Doubles as Confidence in Technology Grows

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions